LGALS3 and heart failure: In another population-based cohort, galectin-3 was associated with all-cause mortality (HR: 1.12, p < 0.001), cardiac death (HR: 1.15, p = 0.033), and heart failure (HR: 1.10, p = 0.049) [27].